Couturier A - Search Results

1

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.

Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA. Garber AJ, et al. Among authors: couturier a. Diabetes Obes Metab. 2008 Nov;10(11):1047-56. doi: 10.1111/j.1463-1326.2008.00859.x. Epub 2008 Feb 18. Diabetes Obes Metab. 2008. PMID: 18284434 Clinical Trial.

2

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.

Rosenstock J, Kim SW, Baron MA, Camisasca RP, Cressier F, Couturier A, Dejager S. Rosenstock J, et al. Among authors: couturier a. Diabetes Obes Metab. 2007 Mar;9(2):175-85. doi: 10.1111/j.1463-1326.2006.00698.x. Diabetes Obes Metab. 2007. PMID: 17300593 Clinical Trial.

3

Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.

Schweizer A, Dejager S, Foley JE, Couturier A, Ligueros-Saylan M, Kothny W. Schweizer A, et al. Among authors: couturier a. Diabetes Obes Metab. 2010 Jun;12(6):485-94. doi: 10.1111/j.1463-1326.2010.01215.x. Diabetes Obes Metab. 2010. PMID: 20518804

4

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials.

Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W. Ligueros-Saylan M, et al. Among authors: couturier a. Diabetes Obes Metab. 2010 Jun;12(6):495-509. doi: 10.1111/j.1463-1326.2010.01214.x. Diabetes Obes Metab. 2010. PMID: 20518805

5

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.

Matthews DR, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley JE, Zinman B. Matthews DR, et al. Among authors: couturier a. Diabetes Obes Metab. 2010 Sep;12(9):780-9. doi: 10.1111/j.1463-1326.2010.01233.x. Diabetes Obes Metab. 2010. PMID: 20649630 Clinical Trial.

6

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.

Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S. Pratley RE, et al. Among authors: couturier a. Diabetes Care. 2007 Dec;30(12):3017-22. doi: 10.2337/dc07-1188. Epub 2007 Sep 18. Diabetes Care. 2007. PMID: 17878242 Clinical Trial.

7

Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetes.

Schweizer A, Couturier A, Foley JE, Dejager S. Schweizer A, et al. Among authors: couturier a. Diabet Med. 2007 Sep;24(9):955-61. doi: 10.1111/j.1464-5491.2007.02191.x. Epub 2007 May 17. Diabet Med. 2007. PMID: 17509069 Clinical Trial.

8

Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus.

Kikuchi M, Haneda M, Koya D, Tobe K, Onishi Y, Couturier A, Mimori N, Inaba Y, Goodman M. Kikuchi M, et al. Among authors: couturier a. Diabetes Res Clin Pract. 2010 Sep;89(3):216-23. doi: 10.1016/j.diabres.2010.04.017. Diabetes Res Clin Pract. 2010. PMID: 20537746 Clinical Trial.

9

Protective Role of the Podocyte IL-15 / STAT5 Pathway in Focal Segmental Glomerulosclerosis.

Niasse A, Louis K, Lenoir O, Schwarz C, Xu X, Couturier A, Dobosziewicz H, Corchia A, Placier S, Vandermeersch S, Hennighausen L, Frère P, Galichon P, Surin B, Ouchelouche S, Louedec L, Migeon T, Verpont MC, Yousfi N, Buob D, Xu-Dubois YC, François H, Rondeau E, Mesnard L, Hadchouel J, Luque Y. Niasse A, et al. Among authors: couturier a. Kidney Int Rep. 2024 Jan 10;9(4):1093-1106. doi: 10.1016/j.ekir.2024.01.010. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765560 Free PMC article.

10

Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.

Crochet G, Iacoboni G, Couturier A, Bachy E, Iraola-Truchuelo J, Gastinne T, Cartron G, Fradon T, Lesne B, Kwon M, Gounot R, Martínez-Cibrian N, Castilla-Llorente C, Abrisqueta P, Guerreiro M, Sarkozy C, Aspa-Cilleruelo JM, Camus V, Guidez S, Chauchet A, Deconinck E, Bouabdallah K, Bosch F, Barba P, Morschhauser F, Houot R. Crochet G, et al. Among authors: couturier a. Blood. 2024 Apr 24:blood.2024024526. doi: 10.1182/blood.2024024526. Online ahead of print. Blood. 2024. PMID: 38657242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page